A 10 mg Survodutide vial mixed with 2 ml of bacteriostatic water holds 5 mg/ml. A 600 mcg dose is 0.12 ml — 12 units on a U-100 insulin syringe — and the vial holds 16 doses of that size.
Units on a U-100 insulin syringe (100 units = 1 ml) for Survodutide doses from 600 mcg to 4.8 mg, by how much bacteriostatic water is in a 10 mg vial. The highlighted row is the 600 mcg dose used above.
| Dose | 1 ml water 10 mg/ml | 2 ml water 5 mg/ml | 3 ml water 3.33 mg/ml | Doses per vial |
|---|---|---|---|---|
| 600 mcg | 6 u 0.060 ml | 12 u 0.12 ml | 18 u 0.18 ml | 16 |
| 2.4 mg | 24 u 0.24 ml | 48 u 0.48 ml | 72 u 0.72 ml | 4 |
| 3.6 mg | 36 u 0.36 ml | 72 u 0.72 ml | 1.08 ml over 100 u | 2 |
| 4.8 mg | 48 u 0.48 ml | 96 u 0.96 ml | 1.44 ml over 100 u | 2 |
A 12-unit draw fits comfortably on a 0.3 ml insulin syringe (30-unit capacity), whose 1-unit (often half-unit) markings are easier to read than the 2-unit ticks on a 1 ml syringe.
Unit math only, not a dosing recommendation. The dose range is what published protocols and trials describe; see the Survodutide guide for sources.
Survodutide is a once-weekly dual GLP-1 / glucagon receptor agonist under clinical development for obesity and metabolic dysfunction–associated steatohepatitis (MASH). Early trials show deep weight-loss effects comparable to the next-generation incretin class.
Half-life: Approximately 5 days (once-weekly dosing)
Typical dose range: Trial titration: 0.6 → 2.4 → 3.6 → 4.8 mg weekly
Class: Dual GLP-1 / glucagon receptor agonist
Regulatory status: Investigational. Not FDA approved. Phase III trials ongoing for obesity and MASH.
Read the full Survodutide guide → — mechanism, side effects, storage, regulatory status and citations. Or browse the whole peptide glossary.
Calculators for related peptides: Liraglutide, Retatrutide, Semaglutide, Tirzepatide, AOD-9604.
Need a different unit or a different question? The peptide dose converter moves a dose between mcg, mg and IU, and the Survodutide half-life chart shows how concentration accumulates across a dosing cadence. Loading Survodutide into a reusable 3 ml pen instead of drawing it with a syringe? The peptide pen calculator turns the same vial into mcg per click and clicks to dial. All of them are listed on the free peptide tools page.
Both. This Survodutide calculator converts vial strength, bacteriostatic-water volume, and target dose into milliliters and insulin-syringe units. It does not recommend a medical dose.
This page is pre-filled with 2 ml of bacteriostatic water for a 10 mg Survodutide vial because that is a common research ratio. You can adjust the water amount in the full calculator.
12 units on a U-100 insulin syringe, when a 10 mg vial is mixed with 2 ml of bacteriostatic water (5 mg/ml). That is 0.12 ml. With a different amount of water the unit count changes — the dose chart on this page lists 1 ml, 2 ml, 3 ml mixes.
16 doses of 600 mcg. The number of doses depends only on vial strength and dose size — adding more or less water changes the volume of each draw, not how many draws the vial holds.
No. It only performs unit math. Dosing, titration, and whether Survodutide is appropriate are clinical decisions that should be made with a licensed healthcare professional.
Peptide Protocol remembers your Survodutide vial, shows the units for every dose, tracks what is left, and rotates injection sites for you.
Get the iPhone app →Educational use only. Peptide Protocol is an informational tool. Nothing on this page constitutes medical advice. Many peptides are prescription-only or restricted in your jurisdiction. Always consult a licensed healthcare professional before injecting any compound.